Odawara, M., Nishi, H., Kodera, S., Kondo, M., & Nangaku, M. (2025). Cost-Effectiveness of Empagliflozin in CKD with or without Albuminuria. Clinical journal of the American Society of Nephrology, 20(1), 50. https://doi.org/10.2215/CJN.0000000582
Citace podle Chicago (17th ed.)Odawara, Motoki, Hiroshi Nishi, Satoshi Kodera, Masahide Kondo, a Masaomi Nangaku. "Cost-Effectiveness of Empagliflozin in CKD with or Without Albuminuria." Clinical Journal of the American Society of Nephrology 20, no. 1 (2025): 50. https://doi.org/10.2215/CJN.0000000582.
Citace podle MLA (9th ed.)Odawara, Motoki, et al. "Cost-Effectiveness of Empagliflozin in CKD with or Without Albuminuria." Clinical Journal of the American Society of Nephrology, vol. 20, no. 1, 2025, p. 50, https://doi.org/10.2215/CJN.0000000582.